Drug intelligence / Profile preview

fermented brown seaweed

Development stage: Preclinical
Lead developer: Oceanium
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Fermented brown seaweed is an investigational nutraceutical derived from the edible brown algae, *Alaria esculenta*, also known as winged kelp. It is being studied for its potential health benefits, particularly its effects on glucose metabolism and gut health. Brown seaweed is a rich source of bioactive compounds, including minerals, polyphenols, and dietary fibers such as fucoidan, laminarin, and alginate. The fermentation process is intended to improve food safety, shelf-life, and sensory properties, as well as potentially enhance the bioavailability and activity of its components. A clinical trial is evaluating whether intake of fermented brown seaweed can lower postprandial blood glucose levels and favorably influence the composition of the gut microbiota in healthy individuals.

Other names: fermented Alaria Esculentafermented winged kelp

Beyond the preview

Go deeper on fermented brown seaweed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fermented brown seaweed.

Explore the full profile